MDM2 and p53 coexpression is associated with poor prognosis in renal cell carcinoma patients undergoing radical nephrectomy : 038
Partial nephrectomy for renal cell carcinoma in single kidneys : 039
Evolution of laparoscopic partial nephrectomy (LPN) in the treatment of solitary renal mass < 4 cm : 040
Caval excision or replacement in the management of renal cell carcinoma : 041
The treatment of pulmonary emboli in patients with renal cell carcinoma associated with venous extension : 042
Outcome of debulking nephrectomy for metastatic renal cell carcinoma in unselected patients in a UK cancer centre : 043
Recurrent disease following radical nephrectomy - the case for surgery : 044
ODMIT-C : A multi-centre prospective randomised trial of a single post-operative intravesical dose of mitomycin-C to prevent bladder recurrence following nephroureterectomy for upper tract TCC (UTTCC)
Report on the early efficacy and tolerability of 1125 permanent prostate brachytherapy from a UK multi-institutional database : 046
Prostate brachytherapy : 7-year biochemical relapse-free survival from 500 patients
Comparative video-linked motion analyses of open, laparoscopic and robotic prostatectomy : 048
Operative details and medium-term oncological and functional outcome of robotic-assisted laparoscopic radical prostatectomy : our first 400 cases with a minimum of 1 year follow-up
Comparing oncological and functional outcomes of HIFU with robotic radical prostatectomy for treatment of localised prostate cancer : 050
Does intrafascial dissection during nerve-sparing laparoscopic radical prostatectomy compromise cancer control? : 051
The UK's first 1,000 cases of laparoscopic radical prostatectomy : evidence of multiple learning curves
Experience of robotic radical prostatectomy using the DaVinci S Robot in localised prostate cancer : 053
Are the characteristics of prostate cancer amenable to focal therapy? : 054
Transrectal high intensity focused ultrasound in the treatment of primary localised prostate cancer : 055
Concomitant bladder and prostate cancer : is radiotherapy a factor in correlation?
Survival outcome following hormone manipulation of metastatic prostate cancer : 057
Outcome following robotic-assisted laparoscopic dismembered pyeloplasty : 089
Who needs a robot? : 090
Laparoscopic radical prostatectomy experience in an English county in 2007 : 091
24 hour laparoscopic radical prostatectomy : the standard of care?
Laparoscopic radical prostatectomy - the cost of learning in the UK? : 093
A dual-focus monitor system for laparoscopic skill acquisition - preliminary results using the radical prostatectomy model : 094
A comparative analysis of open, laparoscopic and robotic radical cystectomy for bladder cancer : 095
Laparoscopic radical cystectomy : initial experience from a single UK centre
Results from a prospective study comparing quality of life issues related to the open versus laparoscopic approach to the kidney : 097
The BAUS laparoscopic nephrectomy audit : increased volume, improved outcomes
Laparoscopic retroperitoneal lymph node dissection (LRPLND) in the management of clinical stage I germ cell tumours (GCT) : Fifteen years follow-up from a large European series
Hem-o-lok clips for the renal hilum : are they safe?
Should the presence of urinary tract infection exclude patients with haematuria from rapid evaluation protocols? : 101
The prevalence of chronic kidney disease in the microscopic haematuria clinic : 102
The use of NMP22 as a point of care test for urothelial cancer in a one stop haematuria clinic : 103
What is the natural history of frank haematuria after initial negative investigations? : 104
Does fluorescence enhanced cystoscopy and transurethral resection of bladder cancer improve the quality of resection, accuracy of staging and patients care? : 105
Does the high-grade and low-grade histological sub-classification of G2 pT1 TCC influence recurrence and progression rates : 106
Are we treating muscle invasive bladder cancer quicker? Changes over a 17 year period : 107
The Influence of oesophageal Doppler monitoring on fluid administration and outcome in cystectomy : 108
The UK'S volume-outcome relationship for radical cystectomy : 109
Laparoscopic radical cystectomy in an elderly patient group : an initial single centre UK series of 60 patients
A three centre experience of orthotopic neobladder. Reconstruction after radical cystectomy - our experience, results and follow up of 104 patients : 111
Robotic assisted radical cystectomy : oncologic and functional outcomes at up to 3.5 years
The natural history of a raised PSA without invasive investigation : P01
The value of PSA testing in men older than 65 years : P02
Abstract withdrawn. : P03
Pharmacokinetic description of MR enhancement patterns as a means to differentiate between malignant prostate lesions and normal peripheral zone : P04
Correlation of apparent diffusion coefficient with cell density in prostate cancer at 3 Tesla MRI : P05
Magnetic resonance imaging of the prostate following high intensity focused ultrasound (HIFU) : P06
The accuracy of prostate biopsies in predicting final histological outcome. An audit of 200 radical prostatectomy specimens : P07
Prognostic value of TRUS biopsy in patients over 70 years with intermediate PSA : a 10 year follow up study
A validated nomogram to predict which patients need repeat extended core prostate biopsy : P09
A modified ‘template’ transperineal prostate biopsy technique - can side-effects be reduced and high cancer detection rates maintained? : P10
Simple drinking advice : an effective treatment for men with moderately severe, uncomplicated, lower urinary tract symptoms
Celecoxib : a useful adjuvant treatment for nocturia in benign prostatic hyperplasia
Haematuria related to benign prostatic hypertrophy : prospective analysis of 165 men identified in a single centre haematuria clinic
Variables and derivatives from the frequency volume chart (FVC) have moderate correlation with the IPSS in men with LUTS - a prospective clinical study : P14
Intra vesical prostatic protrusion on TRUS associated with known predictors of progressive BPH : P15
Relationship between intravesical prostatic protrusion (IPP), prostate volume (PV), IPSS, PSA and uroflowmetry in men with LUTS : P16
Holmium laser ablation of prostate (HoLAP) - an efficacious and safe induction to holmium laser prostatectomy : P17
The case for the holmium laser : P18
Holmium laser enucleation of the prostate (HoLEP) is safe and efficacious in treatment of urinary retention : P19
Does laser ablation prostatectomy lead to oncological compromise? : P20
Is TURP a dying operation? : P21
Voiding success following TURP : P22
Three years of nurse led TURP follow-up, efficient and acceptable to most patients : P23
Quality control in urodynamics : the benefits of audit
Ambulatory urodynamics is the most clinically and cost effective form of urodynamics : P25
Patients' perspective of the efficacy of intradetrusor botulinum toxin-A injections for treatment of neurogenic detrusor overactivity secondary to spinal cord injury : P26
The experience with periodic intra-detru-sor injection of botulinum neurotoxin type-A : P27
A randomised, controlled trial comparing TVT, pelvicol and autologous fascial slings for the treatment of stress urinary incontinence in women : P28
The MiniArc™ single-incision sling system for female stress urinary incontinence : early results
European multicentre study into the efficacy of the argus sling for the treatment of postprostatectomy incontinence : P30
Quality of life outcomes after an artificial urinary sphincter : the patients' perspective
Erosion rate of replacement and redo artificial urinary sphincter compared with primary implantation : P32
Fellowship curriculum in reconstructive urological surgery : when does a trainee become a trainer?
Bladder neck closure in patients with neurogenic bladder and acquired megaurethra : 12 years' experience
Surgical management of uro-rectal fistula following salvage HIFU for recurrent cancer of the prostate after radiotherapy : P35
Medium-term outcome of buccal graft urethroplasty for recurrent bulbar strictures : P36
Sterile abscess formation following periurethral injections for stress urinary incontinence - an unrecognised complication : P37
Management of female urinary retention : 11 years experience
Limited shock wave therapy (SWT) versus Sham treatment in Peyronie's disease : results of a prospective randomised controlled double blind trial
Penile prosthesis insertion in Peyronie's disease : P40
Penile reconstruction for benign disease with the use of skin grafting : P41
Impact of IOG guidance on their management and outcomes of patients with carcinoma of the penis : P42
Specialist review of penile cancer histology is required before supranetwork treatment planning as part of cancer guidelines : P43
Pathological factors affecting survival following lymphadenectomy for penile cancer : P44
Lymph node metastasis in intermediate risk penile squamous cell cancer - a multi-centre experience : P45
Multi-institutional evaluation of sentinel node biopsy for penile carcinoma : P46
Management of chronic ulceration after radiotherapy for penile cancer : P47
Surgical reconstruction in men with advanced genital tumours; is palliative surgery a viable option? : P48
Does teaching affect outcome with major open surgery? : P49
Revalidation in urology. Validating a questionnaire to address the “Relationships with Patients” aspect of “Good Medical Practice” : P50
The diagnostic urologist : is this what ‘Office Urology’ should be?
Ten years of training - a urological training scheme audit revisited : P52
The threat to the consultant urological surgeon - is it real? : P53
The use of standardised consent forms in urology : the gold standard in documentation
The procedure band, a simple way to prevent wrong site surgery? - a 40,000 patient trial : P55
Survey of charity services supporting urological patients with cancer : P56
The successful sustainable elimination of a waiting list for urology outpatients : P57
Clinical coding of urological outpatient referral activity - an insight into previously uncharted territory : P58
Choose and book - how efficient is it? : P59
Economic burden of bladder cancer in the UK : P60
Is your department missing out? The hidden cost of the internal referral : P61
Tackling the tackle - are too many cases of genital chlamydial infection presenting as acute epididymitis slipping through the urological net? : P62
To cell salvage or not to cell salvage; is cost the question? : P63
ESWL for ureteric stones : do decompression tubes matter?
Is there a difference in prevalence of Randall's plaque in stone formers versus non-stone formers : P65
Incidental stones and metabolic abnormalities in potential kidney donors : an increasingly common challenge
A study assessing the use of 4D ultrasound in percutaneous renal intervention with the aid of an ultrasound phantom and fluoroscopic control : P67
Tubeless percutaneous nephrolithotomy in staghorn stones : P68
Anterior percutaneous nephrolithotomy : implementation in a UK tertiary referral centre
Risk factors and outcomes of percutaneous nephrolithotomy (PCNL) in spinal cord injured patients : P70
Contemporary percutaneous nephrolithotomy : intracorporeal techniques to improve stone clearance
Whitaker test - 25 year assessment of functional utility in PUJ disorder : P72
Conservative management of PUJ obstruction : P73
Holmium laser endopyelotomy for pelviureteric junction (PUJ) stenosis following pyeloplasty : P74
Initial experience with the Resonance™ metallic stent for antegrade ureteric stenting : P75
The Memokath™ 051 thermo-expandable metallic stent for ureteric obstruction : long-term experience
Bone segmentation using a CT based statistical shape model for image guidance in robot assisted prostatectomy : P77
Feasibility of magnetic resonance cystography in the surveillance of augmentation and substitution cystoplasty : P78
Characterisation of putative prostate epithelial stem cell derived colonies in monolayer culture : P79
Superficial muscarinic receptors (M2 and M3) in patients with detrusor overactiv-ity (DO) and the effect of Botulinum toxin type A (BoNT/A) : P80
Establishment of an in vitro model of mechanical stretch-induced renal tubular cell apoptosis : P81
Differential expression of the HD5 antimicrobial peptide in the human urinary tract : P82
ERK5 is overexpressed in prostate cancer and represents a potential target for drug development : P83
The role of ZEB1 in bladder cancer : P84
Up-regulation of Flotillin 2 is associated with urothelial cell carcinoma progression : P85
Targeting Farnesoid X receptor in bladder cancer cells : P86
CD133 is a marker for early proliferative cells but not cancer stem-cells in renal cell carcinoma : P87
Hypoxia and angiogenesis in primary clear cell renal carcinoma and its effect on patient prognosis : P88
Does bladder neck resection prior to I125 LDR brachytherapy improve post-implant urinary toxicity? A match-paired analysis : U01
Holmium laser bladder neck incision at time of volume study in obstructed men undergoing I125 brachytherapy reduces risk of urinary retention : U02
The evaluation of lifelong erectile dysfunction with nocturnal penile tumescence rigican (NPTR) testing combined with a phosphodiesterase type 5 inhibitor (PDE5I) : U03
Penile prosthesis insertion in cases of severe penile fibrosis : U04
Efficacy and tolerability of hypofractionated conformal radiotherapy for good prognosis carcinoma of the prostate : U05
The British Association of Urological Surgeons Section of Oncology Urological Cancer Observatory Project : U06
Is laparoscopic renal cryoablation safe for renal tumours > 3 cm? A European multicentre experience : U07
Is CXCR-4 a prognostic indicator in renal cell carcinoma? : U08
Cancer-specific survival of node-positive renal cell cancer after radical nephrec-tomy and lymphadenectomy in the absence of other metastases : U09
Using novel governance tools for monitoring surgical performance during a surgeon's learning curve for laparoscopic prostatectomy : U10
‘Scarless’ nephrectomy and other laparosccopic procedures using a novel laparoscopic port (r-PORTTM) : U11
Urodynamic evaluation of cerebral palsy : U12
Botox in augmented bladder - is it effective? : U13
Effect of botulinum toxin-A on dorsal root ganglia P2X3 receptor expression in an animal model of bladder overactivity A SAHAI : U14
Audit of quality control in paediatric urodynamics : U15
The value of negative dipstick for haematuria in patients undergoing surveillance for non-invasive bladder tumours - a prospective clinical study : U16
Electro-motive drug administration (EMDA) of intravesical mitomycin-C in patients with high-risk non-invasive bladder cancer and failure of BCG immunotherapy : U17
Performance of EORTC superficial bladder cancer risk tables in a local UK population : U18
Enhanced Recovery After Surgery (ERAS) protocol in patients undergoing radical cystectomy for bladder cancer - a prospective controlled study of surgical outcomes : U19
Radical cystectomy for T4 bladder cancer : U20
Early re-resection of high risk non muscle invasive bladder cancer - where should we draw the line? : U21
The surgical management of chronic testicular pain : U22
Developing a strategy to control the blockage of urinary catheters : randomized cross-over study
Does allowing men to watch their video flexible cystoscopy influence pain experienced during the procedure? : U24
A long-term indwelling thermo-expand- able metal stent (Memokath® 051 CW) in the treatment of chronic ureteric strictures : U25
Prospective randomised trial comparing the Bard Inlay™ ureteric stent with the Boston Scientific Polaris™ ureteric stent using the validated ureteric stent symptom questionnaire : U26
Initial experience with BackStop - preventing retropulsion during ureteroscopy : U27